Abstract
A small-molecular-weight drug originally developed to treat cancer produces sustained reduction in body weight in obese mice by a novel hypothalamic mechanism. The findings suggest new targets for the development of antiobesity drugs.
| Original language | English |
|---|---|
| Pages (from-to) | 335-336 |
| Number of pages | 2 |
| Journal | Nature Medicine |
| Volume | 8 |
| Issue number | 4 |
| DOIs | |
| State | Published - 2002 |